Artisan Partners Limited Partnership Reduces $6M in Henry Schein, Inc. ($HSIC)

Key Points

  • Artisan Partners Limited Partnership changed its Henry Schein, Inc. ($HSIC) stake by 1.1% last quarter, cutting to 6,573,023 shares worth $527.09 million.
  • Wall Street's consensus rating on $HSIC is Buy and an average price target of $88.07.
  • $HSIC last traded around $80.19.

Artisan Partners Limited Partnership trimmed its position in Henry Schein, Inc. ($HSIC) by 1.1% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,573,023 shares of Henry Schein, Inc. after selling 74,355 shares during the quarter. Artisan Partners Limited Partnership's holdings in Henry Schein, Inc. were worth $527.09 million as of its most recent filing.

Henry Schein, Inc. ($HSIC) Stock

Last price$80.19
Market cap$9.26B
P/E ratio24.55
Forward P/E13.74
PEG ratio1.79
Beta0.82
52-week low$61.95
52-week high$89.29
50-day MA$75.32
200-day MA$73.43
Current ratio1.36
Quick ratio0.56
Debt-to-equity0.78

Henry Schein, Inc. Earnings

EPS (ttm)$3.31
Revenue (ttm)$13.38B
Revenue growth6.3%
Net margin3.0%
Return on equity8.8%
Next earningsMay 5, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$88.07
High target$100.00
Low target$64.00
Analysts covering15

About Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

ExchangeNasdaqGS
SectorHealthcare
IndustryMedical Distribution
HeadquartersMelville, NY
CEOMr. Andrea Albertini
Employees25,000

See Also

This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.